Clinical Trials Browser

Phase 1 × Methylprednisolone Hemisuccinate × Plasma cell × Clear all

NCT03110822 2023-11-01

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Phase 1 Recruiting

Multiple Myeloma